| Routine-screening population | | |
|
|
| Age, years | | |
| 50–54 | 55 | 26.8 |
| 55–59 | 81 | 39.5 |
| 60–64 | 69 | 33.7 |
|
|
| Menopausal statusa | | |
| Pre-menopausal | 5 | 2.7 |
| Peri-menopausal | 9 | 4.9 |
| Post-menopausal | 150 | 82.4 |
| Not reported/unknown | 18 | 9.9 |
|
|
| Colposcopy population | | |
|
|
| Age, years | | |
| 35–49 | 13 | 15.7 |
| 50–54 | 33 | 39.8 |
| 55–59 | 22 | 26.5 |
| 60–70 | 15 | 18.1 |
|
|
| Reason for referral population study eligibility | | |
| Confirmed CIN2+ on biopsy | 15 | 18.1 |
| Moderate dyskaryosis on cytology | 9 | 10.8 |
| Severe dyskaryosis on cytology | 4 | 4.8 |
| HPV triageb | 55 | 66.3 |
|
|
| Age of women with CIN2+, years | | |
| 35–49 | 5 | 27.8 |
| 50–54 | 6 | 33.3 |
| 55–59 | 3 | 16.7 |
| 60–70 | 4 | 22.2 |
